Stocksigma LogoStocksigma Logo

Sotac Pharmaceuticals Schedules Board Meeting on 13th Nov'26 to Consider H1 Results

Sotac Pharmaceuticals announced that its Board of Directors will meet on 13th Nov'26 to consider, approve, and take on record the unaudited standalone and

Sotac Pharmaceuticals Schedules Board Meeting on 13th Nov'26 to Consider H1 Results

Sotac Pharmaceuticals Ltd 路 Intimation 路 13 Nov 2026, 5:30 am

Sotac Pharmaceuticals Schedules Board Meeting on 13th Nov'26 to Consider H1 Results Sotac Pharmaceuticals announced that its Board of Directors will meet on 13th Nov'26 to consider, approve, and take on record the unaudited standalone and consolidated financial results for the half year ended 30th Sep'26. Consequently, the trading window for company insiders remains closed from 1st Oct'26 until 48 hours post the declaration of the financial results.

Original exchange filing (PDF)

More announcements from Sotac Pharmaceuticals Ltd

All Sotac Pharmaceuticals Ltd announcements